Acrivon Therapeutics, Inc. — SCHEDULE 13G/A Filings
5 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 5 SCHEDULE 13G/A documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-25-112501 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001875620-25-000020 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-081605 | Jun 4, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-049618 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-062201 | May 1, 2025 | — |